Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 30014 matches for

The Wellcome Trust announced that Prof Mark McCarthy has been give a Senior Investigator Award.

Logo of the Wellcome Trust.

2026 Lewis Group (MRC Enterprise iCase): High throughput human systems for target discovery and validation in tissue fibrosis

2026 Raman Group (MRC Enterprise iCase): Development of Cardiac Diffusion Tensor Imaging for Clinical Evaluation of Cardiomyopathies

2026 Zhang Group (MRC Enterprise iCase): Developing Accountable AI for Automated Cardiovascular MR Processing towards Precision Diagnostic Reporting

2026 Antanaviciute Group (iCase): The GI Chronicle project: Exploring the effect of age on intestinal epithelial & immune function

2026 Antanaviciute Group: Decrypting human intestinal development

2026 Chakraverty Group: Identifying novel CD4+ T cell platforms for immunotherapy

2026 Davies Group: Genomics and Genome Editing

2026 Goriely Group: Investigating the role of genetic mosaicism in congenital disease

2026 Kassouf Group: Understanding the principles of gene expression in health and disease

2026 Koohy Group: Decoding the underlying rules of T cell response by AI and Machine-Learning strategies

2026 Mead Group: Gene-Environment Initiated Disease Progression in Myeloproliferative Neoplasms

2026 Ogg Group: Discovery of new approaches to treat skin inflammation

2026 Nerlov Group: Single Cell Biology and Machine Learning in Blood Development, Cancer and Ageing

2026 Sharma Group: Comparative Analysis of TCR-Mediated Cytotoxicity Using Genome-Wide CRISPR Screens to Identify Host Factors in Natural vs. Vaccine-Induced Immunity

2026 Simmons Group: Engineering Intestinal Mesenchymal Niches to Promote Epithelial Barrier Health Through Life

2026 Twigg Group: Building the skull – normal and abnormal development

2026 Vyas Group: New Immune Therapies For Acute Myeloid Leukaemia (AML) And Other Cancers

2026 Akbar Group: Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential

2026 Antoniades Group: Cross-talk between adipose tissue and the cardiovascular system in humans - Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets

2026 Bhattacharya Group: Targeting chemokine inhibitors to the inflamed islet

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Night-time changes in metabolism may be driving common liver disease

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.

Oxford recruits first participant in Europe for heart inflammation treatment study

It's beginning to look a lot like Gutmas!

RDM Careers Day 2025: exploring pathways within and beyond academia

Professor James Chalmers to join the Radcliffe Department of Medicine

Oxford scientists map the cells that drive Crohn’s disease fistulas